Thus, preexisting IgG antibodies, age, and CD4 T<sub>E+EM</sub> cells could serve as predictors for the successful influenza vaccination in this at-risk population informing targeted interventions to improve vaccine responses, prevent infections, and reduce influenza-associated comorbidities. Here, CD4 is linked to infection.